Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on May 7, 2025
aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update
GlobeNewswire
·
May 7, 2025
Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis on track for the third quarter of 2025. Blinded baseline demographics and disease characteristics from Phase 3 EFZO-FIT™ study and current U.S. epidemiology and treatment …
Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
-- Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 2 Dose-Finding Study of VAX-24 in Healthy Infants; Balance of Data Expected by End of 2025 -- -- Initiated Second and Final Stage of VAX-31 Infant Phase 2 Dose- …
OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System
GlobeNewswire
·
May 7, 2025
WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its Trauma and …
Soleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
REDWOOD CITY, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided an update on the U.S. launch of VYKATTM …
Design Therapeutics Highlights Momentum Across Lead GeneTAC® Programs and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
Phase 1 Single Ascending Dose Trial of DT-216P2 for Friedreich Ataxia (FA) Program Ongoing Reported Favorable Phase 1 Data for DT-168 for Fuchs Endothelial Corneal Dystrophy (FECD) Program Well-Capitalized with Cash and Securities of $229.7 Million to Fund …
Syndax Announces Publication of Pivotal Revumenib Data in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia in the Journal Blood
GlobeNewswire
·
May 7, 2025
– Primary endpoint met in R/R mNPM1 AML patients in pivotal Phase 2 portion of the AUGMENT-101 trial – – Robust remission rates in heavily pre-treated R/R mNPM1 AML population with nearly 50% overall response rate – – sNDA for revumenib in R/R mNPM1 AML …
Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference
GlobeNewswire
·
May 7, 2025
NEWTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s …
IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
May 7, 2025
Phase 1 clinical data of INB-100 continues to demonstrate long-term durable remissions, with 100% of treated Acute Myeloid Leukemia (AML) patients remaining relapse-free with median follow-up of 20.1 months as of January 17, 2025, as presented at the 2025 …
Symbotic Reports Second Quarter Fiscal Year 2025 Results
GlobeNewswire
·
May 7, 2025
WILMINGTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced financial results for its second quarter of fiscal year 2025, which ended on March 29, 2025. …
Kratos Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
First Quarter 2025 Revenues of $302.6 Million Reflect 9.2 Percent Growth and 7.4 Percent Organic Growth Over First Quarter 2024 Revenues of $277.2 Million First Quarter 2025 Consolidated Book to Bill Ratio of 1.2 to 1 and Bookings of $365.6 Million Last …
Best Fortune Teller Online For Accurate Fortune Telling In 2025 - The Psychic Experts
GlobeNewswire
·
May 7, 2025
New York City, May 07, 2025 (GLOBE NEWSWIRE) -- Connect with the best fortune teller online offering accurate fortune telling and powerful insights about the future, love life, career path, and more. SAN FRANCISCO, CA, May 07, 2025 (GLOBE NEWSWIRE) – The …
Best Probiotic For Women: Top Strains for Gut Health, Vaginal health & Constipation - Women Over 40,50,60 - Bioma
GlobeNewswire
·
May 7, 2025
Birštonas, May 07, 2025 (GLOBE NEWSWIRE) -- In this health-conscious era, choosing a good probiotic for women is no longer a supplement option—it's a lifestyle choice for women's health, digestion, and well-being; with so many probiotics on the market, …
Multiverse Computing Named to the 2025 CB Insights' List of the 100 Most Innovative AI Startups
GlobeNewswire
·
May 7, 2025
DONOSTIA, Spain, May 07, 2025 (GLOBE NEWSWIRE) -- Multiverse Computing, the leader in AI model compression, has been named to the 2025 CB Insights' List of the 100 Most Innovative AI Startups. The recognition highlights the company's breakthroughs at the …
XRP News: Vaultro Finance $VLT Token To Unlock Real Utility on XRP Ecosystem — From Fund Creation to Governance and Staking Rewards
GlobeNewswire
·
May 7, 2025
SINGAPORE, May 07, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance, the first decentralized index fund protocol built on the XRP Ledger, is preparing for the public launch of its native utility token $VLT, on 8th of May 2025. As excitement builds around this …
The Best Place to Buy SARMs Online and OTC: Top SARM Brand & Company for Muscle Growth & Fat Loss - Safe Legal SARMS for Sale - CrazyBulk
GlobeNewswire
·
May 7, 2025
New York City, May 07, 2025 (GLOBE NEWSWIRE) -- The best place to buy SARMs is presented by CrazyBulk SARMs are the hottest trend in bodybuilding right now. Bodybuilders, weightlifters, and athletes everywhere are buying SARMs (Selective Androgen Receptor …
Cryptade Exchange Partners with Leading Institutions to Promote Global Compliance
GlobeNewswire
·
May 7, 2025
New York, May 07, 2025 (GLOBE NEWSWIRE) -- Cryptade Exchange, a leading global compliant digital asset trading platform, recently announced deep strategic partnerships with several world-class financial institutions. These collaborations span key areas …
More German Traders Choose DBLfin to Maximize Gains and Reduce Risk
GlobeNewswire
·
May 7, 2025
London, UK, May 07, 2025 (GLOBE NEWSWIRE) -- In an increasingly volatile global market, German traders are turning to brokers that offer not only fast execution but also clear, secure structures to manage risk. According to rising numbers of DBLfin reviews …
Best Legal Steroids for Muscle Growth & Testosterone Booster – Top Legal Supplements For Bulking, Cutting & Strength 2025 – By Wolfson Brands
GlobeNewswire
·
May 7, 2025
Glassgow, May 07, 2025 (GLOBE NEWSWIRE) -- Best Legal Steroids For Fastest Muscle Growth While the options in workout supplements are endless, here is a list of the five best options based on efficiency, results, price, and customer reviews. Read the basic …
Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units
GlobeNewswire
·
May 7, 2025
CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
authID Announces Closing of $2,100,000 Registered Direct Offering
GlobeNewswire
·
May 7, 2025
DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- authID Inc. (NASDAQ: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, announced on May 6, 2025, it entered into a definitive agreement, for a …